The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: A case study with chitosan-4-thiobutylamidine conjugate

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1185-1192

  Sakloetsakun, Duangkamon ^a   Perera, Glen ^a   Hombach, Juliane ^a   Millotti, Gioconda ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

chitosan TBA; mucoadhesion; nanoparticles; thiomer; vehicles

Indexed keywords

CAPRYLIC TRIGLYCERIDE; CHITOSAN 4 THIOBUTYLAMIDINE; CREMOPHOR; FLUORESCEIN DIACETATE; MACROGOL; MACROGOL 300; MACROGOL 6000; MIGLYOL; NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CASE STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; EVALUATION; GELATION; MEAN RESIDENCE TIME; MUCOADHESION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SMALL INTESTINE; ZETA POTENTIAL;

ADHESIVENESS; ADMINISTRATION, ORAL; ANIMALS; CHITIN; INTESTINAL MUCOSA; NANOPARTICLES; PHARMACEUTICAL VEHICLES; SWINE;

EID: 78649905059     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9479-8     Document Type: Article

References (30)

1. J Smart 2005 The basics and underlying mechanisms of mucoadhesion Adv Drug Deliv Rev 57 11 1556 1568 1:CAS:528:DC%2BD2MXhtFSis7fP 10.1016/j.addr.2005. 07.001 16198441 (Pubitemid 41443469)
2. H Takeuchi J Thongborisute Y Matsui H Sugihara H Yamamoto Y Kawashima 2005 Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems Adv Drug Deliv Rev 57 11 1583 1594 1:CAS:528:DC%2BD2MXhtFSis7fL 10.1016/j.addr.2005.07.008 16169120 (Pubitemid 41443471)
3. Y Akiyama N Nagahara E Nara M Kitano S Iwasa I Yamamoto, et al. 1998 Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites J Pharm Pharmacol 50 2 159 166 1:CAS:528:DyaK1cXit1eltb8%3D 9530983
4. A Coupe S Davis I Wilding 1991 Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects Pharm Res 8 3 360 364 1:CAS:528:DyaK3MXitFChtbg%3D 10.1023/A:1015849700421 2052525
5. F Cui F Qian C Yin 2006 Preparation and characterization of mucoadhesive polymer-coated nanoparticles Int J Pharm 316 1-2 154 161 1:CAS:528: DC%2BD28XkvVWrsbk%3D 10.1016/j.ijpharm.2006.02.031 16567070 (Pubitemid 43765702)
6. G Coppi N Sala M Bondi S Sergi V Iannuccelli 2006 Ex-vivo evaluation of alginate microparticles for polymyxin B oral administration J Drug Target 14 9 599 606 1:CAS:528:DC%2BD28XhtlSitL%2FN 10.1080/10611860600864182 17090395 (Pubitemid 44712355)
7. E Hassan J Gallo 1990 A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength Pharm Res 7 5 491 495 1:CAS:528:DyaK3cXltVehtbk%3D 10.1023/A:1015812615635 1694990
8. V Grabovac D Guggi A Bernkop-Schnürch 2005 Comparison of the mucoadhesive properties of various polymers Adv Drug Deliv Rev 57 11 1713 1723 1:CAS:528:DC%2BD2MXhtFSisL7L 10.1016/j.addr.2005.07.006 16183163 (Pubitemid 41443475)
9. A Bernkop-Schnürch A Weithaler K Albrecht A Greimel 2006 Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system Int J Pharm 317 1 76 81 10.1016/j.ijpharm.2006.02.044 16595166 (Pubitemid 43866341)
10. V Grabovac A Bernkop-Schnürch 2007 Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine Drug Dev Ind Pharm 33 7 767 774 1:CAS:528: DC%2BD2sXotVOgsL8%3D 10.1080/03639040601050163 17654025 (Pubitemid 47123803)
11. T Schmitz I Bravo-Osuna C Vauthier G Ponchel B Loretz A Bernkop-Schnürch 2007 Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system Biomaterials 28 3 524 531 1:CAS:528:DC%2BD28XhtFeiu7jO 10.1016/j.biomaterials.2006.08.017 16979757 (Pubitemid 44602224)
12. Greimel A. Multifunctional polymers: development of nasal peptide drug delivery systems. Innsbruck: University of Innsbruck; 2005.
13. K Albrecht E Zirm T Palmberger W Schlocker A Bernkop-Schnürch 2006 Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties Drug Dev Ind Pharm 32 10 1149 1157 1:CAS:528:DC%2BD28Xht1GntL7P 10.1080/03639040600712334 17090437 (Pubitemid 44721729)
14. A Bernkop-Schnürch V Schwarz S Steininger 1999 Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res 16 6 876 881 10.1023/A:1018830204170 10397608 (Pubitemid 29284199)
15. M Werle M Hoffer 2006 Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine J Control Release 111 1-2 41 46 1:CAS:528:DC%2BD28XhslKjtL8%3D 10.1016/j.jconrel.2005.11.011 16377016 (Pubitemid 43289993)
16. B Loretz A Bernkop-Schnürch 2007 In vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery Nanotoxicology 1 2 139 148 1:CAS:528:DC%2BD2sXhtV2ns77N 10.1080/ 17435390701554200 (Pubitemid 47344128)
17. K Albrecht M Greindl C Kremser C Wolf P Debbage A Bernkop-Schnürch 2006 Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection J Control Release 115 1 78 84 1:CAS:528:DC%2BD28XpvVOhtL0%3D 10.1016/j.jconrel.2006.06.023 16901569 (Pubitemid 44415072)
18. S Mao X Shuai F Unger M Simon D Bi T Kissel 2004 The depolymerization of chitosan: effects on physicochemical and biological properties Int J Pharm 281 1-2 45 54 1:CAS:528:DC%2BD2cXmtFCmurc%3D 10.1016/j.ijpharm.2004.05.019 15288342 (Pubitemid 39024262)
19. M Roldo M Hornof P Caliceti A Bernkop-Schnürch 2004 Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation Eur J Pharm Biopharm 57 1 115 121 1:CAS:528: DC%2BD2cXjsFakug%3D%3D 10.1016/S0939-6411(03)00157-7 14729087 (Pubitemid 38058810)
20. D Guggi N Langoth M Hoffer M Wirth A Bernkop-Schnürch 2004 Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate Int J Pharm 278 2 353 360 1:CAS:528:DC%2BD2cXkslKlsr0%3D 10.1016/j.ijpharm.2004.03.016 15196640 (Pubitemid 38759508)
21. I Bravo-Osuna T Schmitz A Bernkop-Schnürch C Vauthier G Ponchel 2006 Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles Int J Pharm 316 1-2 170 175 1:CAS:528:DC%2BD28XkvVWrtrw%3D 10.1016/j.ijpharm.2006.02.037 16580797 (Pubitemid 43765693)
22. T Goto M Morishita N Kavimandan K Takayama N Peppas 2006 Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats J Pharm Sci 95 2 462 469 1:CAS:528:DC%2BD28XhsFeksL8%3D 10.1002/jps.20566 16381013 (Pubitemid 43241986)
23. VM Leitner GF Walker A Bernkop-Schnurch 2003 Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins Eur J Pharm Biopharm 56 2 207 214 1:CAS:528:DC%2BD3sXmvFSjtrw%3D 10.1016/S0939-6411(03) 00061-4 12957634 (Pubitemid 37072104)
24. I Bravo-Osuna C Vauthier A Farabollini G Palmieri G Ponchel 2007 Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles Biomaterials 28 13 2233 2243 1:CAS:528:DC%2BD2sXhsFCkurc%3D 10.1016/j.biomaterials.2007.01.005 17261330 (Pubitemid 46216448)
25. AF Hofmann JH Pressman CF Code 1983 Controlled entry of orally administered drugs: physiological considerations Drug Dev Ind Pharm 9 7 1077 1109 10.3109/03639048309046314
26. F Ward M Coates 1987 Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting Lab Anim 21 3 216 222 1:STN:280:DyaL2szhtlansw%3D%3D 10.1258/002367787781268693 3626468
27. A Basit J Newton M Short W Waddington P Ell L Lacey 2001 The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs Pharm Res 18 8 1146 1150 1:CAS:528:DC%2BD3MXnt1ekt7o%3D 10.1023/A:1010927026837 11587486 (Pubitemid 32900400)
28. R Hejazi M Amiji 2003 Chitosan-based gastrointestinal delivery systems J Control Release 89 2 151 165 1:CAS:528:DC%2BD3sXjtVegtbg%3D 10.1016/S0168- 3659(03)00126-3 12711440 (Pubitemid 36507012)
29. S Davis J Hardy J Fara 1986 Transit of pharmaceutical dosage forms through the small intestine Gut 27 8 886 892 1:STN:280:DyaL283ns1WmtA%3D%3D 10.1136/gut.27.8.886 3732895
30. J DeSesso C Jacobson 2001 Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats Food Chem Toxicol 39 3 209 228 1:CAS:528:DC%2BD3MXitF2nurw%3D 10.1016/S0278-6915(00)00136-8 11278053 (Pubitemid 32244129)